Comparison of Hydromorphone versus Fentanyl-based Sedation in Extracorporeal Membrane Oxygenation: A Propensity-Matched Analysis.

Pharmacotherapy
Kaitlin M LandolfPenny L Sappington

Abstract

Data comparing sedatives in patients receiving extracorporeal membrane oxygenation (ECMO) are sparse. However, it is known that the ECMO circuit alters the pharmacokinetic properties of medications via drug sequestration of lipophilic agents and increased volume of distribution. This study evaluated the difference in days alive without delirium or coma and the sedative requirements in patients receiving fentanyl versus hydromorphone in ECMO patients. This single-center retrospective observational study evaluated adults receiving ECMO for more than 48 hours and continuous infusion of either fentanyl or hydromorphone for at least 6 hours. Of 148 patients evaluated, 88 received fentanyl and 60 received hydromorphone continuous infusion sedation. Outcomes included delirium-free and coma-free (DFCF) days, narcotic use, and sedative use. There was an increase in the number of DFCF days in the hydromorphone group at day 7 (p=0.07) and day 14 (p=0.08) and a significant reduction in daily fentanyl equivalent exposure. Propensity score matching yielded 54 matched pairs. An 11.1% increase was observed in the proportion of ECMO days alive without delirium or coma in the hydromorphone group at 7 days (53.2% vs 42.1%, p=0.006). Patients in t...Continue Reading

References

Oct 1, 1988·Clinical Pharmacology and Therapeutics·M M ReidenbergD E Drayer
Apr 18, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·N SarhillK A Nelson
Jan 18, 2002·Intensive Care Medicine·E W ElyS K Inouye
Apr 15, 2004·JAMA : the Journal of the American Medical Association·E Wesley ElyRobert S Dittus
Dec 31, 2005·Nucleic Acids Research·David S WishartJennifer Woolsey
Jan 5, 2007·Nucleic Acids Research·David S WishartLori Querengesser
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Pratik P PandharipandeE Wesley Ely
Mar 4, 2008·Critical Care : the Official Journal of the Critical Care Forum·UNKNOWN Irish Critical Care Trials Group
Sep 12, 2009·American Journal of Respiratory and Critical Care Medicine·Margaret A PisaniPeter H Van Ness
Sep 15, 2010·Critical Care Medicine·Yahya ShehabiUNKNOWN SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group
Sep 24, 2010·Intensive Care Medicine·E D WildschutD Tibboel
Apr 24, 2012·Journal of Critical Care·Kiran ShekarJason A Roberts
Oct 17, 2012·Critical Care : the Official Journal of the Critical Care Forum·Kiran ShekarJohn F Fraser
Nov 26, 2014·BMJ : British Medical Journal·Peter M C Klein KlouwenbergOlaf L Cremer
Apr 19, 2015·Critical Care : the Official Journal of the Critical Care Forum·Kiran ShekarJohn F Fraser
Feb 14, 2017·Handbook of Clinical Neurology·A J C SlooterI J Zaal
Apr 5, 2017·Journal of the National Cancer Institute·Xiaoxin I YaoHerbert H Pang
Apr 3, 2018·Journal of Intensive Care Medicine·Vanessa ShurtleffAsad E Patanwala
May 8, 2018·Journal of Thoracic Disease·Vesa ChengKiran Shekar
May 24, 2018·The New England Journal of Medicine·Alain CombesUNKNOWN EOLIA Trial Group, REVA, and ECMONet
Sep 5, 2018·Medical Care·Eduard E VasilevskisE Wesley Ely
Sep 24, 2019·The Annals of Pharmacotherapy·Mitulkumar PatelJohn Papadopoulos

❮ Previous
Next ❯

Citations

Apr 23, 2021·The Annals of Pharmacotherapy·Diane DreuceanKevin R Donahue
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marta TikhomirovBłażej Poźniak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Nursing
C Pasero, M McCaffery
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
Catherine S HeithGwenyth A Fischer
The Cochrane Database of Systematic Reviews
Columba Quigley
Journal of Perianesthesia Nursing : Official Journal of the American Society of PeriAnesthesia Nurses
Julie GolembiewskiJennifer Katke
© 2021 Meta ULC. All rights reserved